Objectives and Supporting Activities
Page Content
| Utilize and expand tools and venues for consistent communication and access to critical information across the network laboratory programs. |
Maintain a team site on the HANC portal for each working group for information sharing and collaborative document development. |
| Ensure standard quality assurance for all of the protocol-specified assays conducted in DAIDS-sponsored network clinical trials across networks and other partners through the development and implementation of a Total Quality Management (TQM) Program. |
Develop, review, and/or modify as needed guidelines for laboratory quality management including performance criteria and mechanisms for restricting protocol testing based on poor proficiency testing performance and guidelines for data and communication flow. |
| Identify and address opportunities to harmonize laboratory processes and procedures to reduce redundancy, increase efficiency and clarify expectations, especially at shared site laboratories. |
Update the Cross-Network PBMC Processing SOP for utilization at network laboratories. |
| Continue collaborating amongst the networks, HANC, DAIDS and SMILE to improve TB diagnostics, TB proficiency testing and participation of labs with TB diagnostic capacity in network protocols where TB is a component. |
Maintain a list of US and non-US labs with reliable TB diagnostic capacity as a resource for networks and their partners when conducting studies when TB is a component |
| Collaborate among the networks, HANC, DAIDS and SMILE to establish a Malaria Laboratory Working Group. |
Identify, evaluate and support malaria laboratories that can:
- Perform technically challenging malaria testing in network clinical studies.
- Conduct evaluations of malaria diagnostic methods for use in HIV-positive participants.
- Implement standard guidelines for laboratory personnel safety.
|